ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1970

Disparities in Access to Specialist Care at the Time of Diagnosis of Systemic Lupus Erythematosus

Lisa Gaynon1, Patricia P. Katz2, Maria Dall'Era3, Laura Trupin2, Lindsey A. Criswell4, Cristina Lanata4, Charles Hemlick5 and Jinoos Yazdany2, 1Internal Medicine, California Pacific Medical Center, San Francisco, CA, 2Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 3Division of Rheumatology, University of California, San Francisco, San Francisco, CA, 4Division of Rheumatology, UCSF, San Francisco, CA, 5Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lupus, quality and race/ethnicity

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Healthcare Disparities in Rheumatology

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Disparities in outcomes among racial/ethnic minorities and individuals with low socioeconomic status with systemic lupus erythematosus (SLE) have been well reported. The degree to which these populations have delayed access to specialists, particularly at the time of diagnosis, is less well described and was the focus of this study.

Methods:  Data were derived from the California Lupus Epidemiology Study (CLUES), a population-based, longitudinal, multi-ethnic cohort of patients with SLE. Data were collected via annual telephone interviews as well as in-person clinical visits. Questions on access to care included time from onset of symptoms to diagnosis of SLE, the specialty of the diagnosing physician, the time until first visit with a specialist (rheumatologist or nephrologist) if not diagnosed by one, and the specialty of the physician currently managing SLE. The significance of the relationships between these variables and race, poverty level, education level and health literacy was determined through chi-squared tests.

Results: This study included 196 patients, with a mean age of 45 (SD 15) years. Thirteen percent had an education level ≤ high school, 34% had limited health literacy and 13% were below 125% of the federal poverty level. The racial/ethnic distribution was 30% Caucasian, 22% Hispanic, 14% African-American and 33% Asian. The time from symptom onset to receiving a diagnosis of SLE varied, with 32% diagnosed in ≤3 months, 22% in 3-6 months, 15% in 6-12 months and 32% in >12 months. There were no significant differences for this outcome by race, education, literacy or poverty level. Of the 84 (43%) patients who received their initial diagnosis from a physician other than a rheumatologist or nephrologist, 64 (76%) were referred to a rheumatologist or nephrologist within 3 months but 20 (24%) experienced a delay >3 months. There was a significant difference in the time to referral to a specialist by race and education level: 64% of African-Americans and 66% of Asians saw a specialist within 3 months of diagnosis, compared with 92% and 85% for Caucasians and Hispanics respectively (p=0.02). For those with an education level ≤ high school, 45% were referred within the first 3 months compared with 81% of those with a higher level of education (p=0.01).

Conclusion:  The time from symptom onset to diagnosis of SLE varied greatly within this population, with up to 32% waiting over 1 year for a diagnosis. Roughly a quarter of SLE patients not initially diagnosed by a rheumatologist or nephrologist experienced a delay in access to specialty care at the time of diagnosis. Of these patients, African-Americans and Asians, as well as those with a lower level of education had the longest delays in accessing specialists.


Disclosure: L. Gaynon, None; P. P. Katz, None; M. Dall'Era, None; L. Trupin, None; L. A. Criswell, None; C. Lanata, None; C. Hemlick, None; J. Yazdany, None.

To cite this abstract in AMA style:

Gaynon L, Katz PP, Dall'Era M, Trupin L, Criswell LA, Lanata C, Hemlick C, Yazdany J. Disparities in Access to Specialist Care at the Time of Diagnosis of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/disparities-in-access-to-specialist-care-at-the-time-of-diagnosis-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disparities-in-access-to-specialist-care-at-the-time-of-diagnosis-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology